참고문헌 (80)

1. 1 Wang L Xie H Xu L Liao Q Wan S Yu Z rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-alpha Signaling Pathway Theranostics 2017 7 3446 60 28912887 

2. 2 Baumgart DC Carding SR Inflammatory bowel disease: cause and immunobiology Lancet 2007 369 1627 40 17499605 

3. 3 Zhang L Xue H Zhao G Qiao C Sun X Pang C Curcumin and resveratrol suppress dextran sulfate sodiuminduced colitis in mice Mol Med Rep 2019 19 3053 60 30816479 

4. 4 Ott C Scholmerich J Extraintestinal manifestations and complications in IBD Nat Rev Gastroenterol Hepatol 2013 10 585 95 23835489 

   상세보기

5. 5 Kim ER Chang DK Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis World J Gastroenterol 2014 20 9872 81 25110418 

   상세보기

6. 6 Muzes G Molnar B Tulassay Z Sipos F Changes of the cytokine profile in inflammatory bowel diseases World J Gastroenterol 2012 18 5848 61 23139600 

   상세보기

7. 7 Seo GS Chae SC Biological therapy for ulcerative colitis: an update World J Gastroenterol 2014 20 13234 8 25309060 

   상세보기

8. 8 Li J Tian H Jiang HJ Han B Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: a meta-analysis World J Gastroenterol 2014 20 15899 909 25400476 

   상세보기

9. 9 Maloy KJ Powrie F Intestinal homeostasis and its breakdown in inflammatory bowel disease Nature 2011 474 298 306 21677746 

   상세보기

10. 10 Takeuchi K Maiden L Bjarnason I Genetic aspects of intestinal permeability in inflammatory bowel disease Novartis Found Symp 2004 263 151 8 discussion 9-63, 211-8 15669640 

    상세보기

11. 11 Xiao B Zhang Z Viennois E Kang Y Zhang M Han MK Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation Theranostics 2016 6 2250 66 27924161 

    상세보기

12. 12 Cherry LN Yunker NS Lambert ER Vaughan D Lowe DK Vedolizumab: an alpha4beta7 integrin antagonist for ulcerative colitis and Crohn's disease Ther Adv Chronic Dis 2015 6 224 33 26336591 

13. 13 Pugliese D Felice C Papa A Gasbarrini A Rapaccini GL Guidi L Anti TNF-alpha therapy for ulcerative colitis: current status and prospects for the future Expert Rev Clin Immunol 2017 13 223 33 27687496 

14. 14 Malek TR The biology of interleukin-2 Annu Rev Immunol 2008 26 453 79 18062768 

    상세보기

15. 15 Bayer AL Pugliese A Malek TR The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation Immunol Res 2013 57 197 209 24214027 

    상세보기

16. 16 De Paoli P Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects Clin Diagn Lab Immunol 2001 8 671 7 11427409 

    상세보기

17. 17 Rosenberg SA IL-2: the first effective immunotherapy for human cancer J Immunol 2014 192 5451 8 24907378 

    상세보기

18. 18 Abo H Flannigan KL Geem D Ngo VL Harusato A Denning TL Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis Front Immunol 2019 10 459 30930900 

19. 19 Smith KA Favata MF Oroszlan S Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics J Immunol 1983 131 1808 15 6352804 

    상세보기

20. 20 Bayer AL Yu A Adeegbe D Malek TR Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period J Exp Med 2005 201 769 77 15753210 

    상세보기

21. 21 Fontenot JD Rasmussen JP Gavin MA Rudensky AY A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 2005 6 1142 51 16227984 

    상세보기

22. 22 Malek TR Yu A Vincek V Scibelli P Kong L CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 Immunity 2002 17 167 78 12196288 

23. 23 Kosmaczewska A Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity Int J Mol Sci 2014 15 18574 92 25322151 

24. 24 Goettel JA Kotlarz D Emani R Canavan JB Konnikova L Illig D Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model Cell Mol Gastroenterol Hepatol 2019 8 193 5 31078723 

    상세보기

25. 25 Koreth J Kim HT Jones KT Lange PB Reynolds CG Chammas MJ Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease Blood 2016 128 130 7 27073224 

    상세보기

26. 26 Saadoun D Rosenzwajg M Joly F Six A Carrat F Thibault V Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis N Engl J Med 2011 365 2067 77 22129253 

    상세보기

27. 27 Pham MN von Herrath MG Vela JL Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes Front Immunol 2015 6 651 26793191 

28. 28 Chassaing B Aitken JD Malleshappa M Vijay-Kumar M Dextran sulfate sodium (DSS)-induced colitis in mice Curr Protoc Immunol 2014 104 15 25 1-15 25 14 24510619 

29. 29 Sann H Erichsen J Hessmann M Pahl A Hoffmeyer A Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice Life Sci 2013 92 708 18 23399699 

30. 30 Lee MO Jung KB Jo SJ Hyun SA Moon KS Seo JW Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells J Biol Eng 2019 13 15 30809271 

    상세보기

31. 31 Jung KB Lee H Son YS Lee JH Cho HS Lee MO In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells FASEB J 2018 32 111 22 28855280 

    상세보기

32. 32 Son MY Sim H Son YS Jung KB Lee MO Oh JH Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells Neuropathol Appl Neurobiol 2017 43 584 603 28235153 

    상세보기

33. 33 Schindelin J Arganda-Carreras I Frise E Kaynig V Longair M Pietzsch T Fiji: an open-source platform for biological-image analysis Nat Methods 2012 9 676 82 22743772 

    상세보기

34. 34 Jung KB Lee H Son YS Lee MO Kim YD Oh SJ Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids Nat Commun 2018 9 3039 30072687 

    상세보기

35. 35 Jung KB Kwon O Lee MO Lee H Son YS Habib O Blockade of STAT3 Causes Severe In Vitro and In Vivo Maturation Defects in Intestinal Organoids Derived from Human Embryonic Stem Cells J Clin Med 2019 8 E976 31277507 

36. 36 Weigmann B Tubbe I Seidel D Nicolaev A Becker C Neurath MF Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue Nat Protoc 2007 2 2307 11 17947970 

    상세보기

37. 37 Mahe MM Aihara E Schumacher MA Zavros Y Montrose MH Helmrath MA Establishment of Gastrointestinal Epithelial Organoids Curr Protoc Mouse Biol 2013 3 217 40 25105065 

    상세보기

38. 38 Jeengar MK Thummuri D Magnusson M Naidu VGM Uppugunduri S Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice Sci Rep 2017 7 3924 28634361 

    상세보기

39. 39 Wang D Dubois RN Richmond A The role of chemokines in intestinal inflammation and cancer Curr Opin Pharmacol 2009 9 688 96 19734090 

    상세보기

40. 40 Liu ZY Zheng M Li YM Fan XY Wang JC Li ZC RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression Theranostics 2019 9 3659 73 31281505 

    상세보기

41. 41 Cho JM Yun SM Choi YH Heo J Kim NJ Kim SH Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKKbeta/NF-kappaB signaling in mice Oncotarget 2018 9 866 80 29416662 

42. 42 Skrzydlewska E Sulkowski S Koda M Zalewski B Kanczuga-Koda L Sulkowska M Lipid peroxidation and antioxidant status in colorectal cancer World J Gastroenterol 2005 11 403 6 15637754 

    상세보기

43. 43 Cao Q Gao X Lin Y Yue C Wang Y Quan F Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes Theranostics 2019 9 7490 505 31695782 

    상세보기

44. 44 Kim YS Ho SB Intestinal goblet cells and mucins in health and disease: recent insights and progress Curr Gastroenterol Rep 2010 12 319 30 20703838 

    상세보기

45. 45 Moncada DM Kammanadiminti SJ Chadee K Mucin and Toll-like receptors in host defense against intestinal parasites Trends Parasitol 2003 19 305 11 12855381 

46. 46 Mohamet L Hawkins K Ward CM Loss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesis J Oncol 2011 2011 352616 21197469 

    상세보기

47. 47 Yan F Wang L Shi Y Cao H Liu L Washington MK Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice Am J Physiol Gastrointest Liver Physiol 2012 302 G504 14 22173918 

48. 48 Huang XL Xu J Zhang XH Qiu BY Peng L Zhang M PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis Inflamm Res 2011 60 727 34 21442372 

49. 49 Dai C Zheng CQ Meng FJ Zhou Z Sang LX Jiang M VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSS-induced colitis Mol Cell Biochem 2013 374 1 11 23271629 

50. 50 Atreya I Atreya R Neurath MF NF-kappaB in inflammatory bowel disease J Intern Med 2008 263 591 6 18479258 

51. 51 Kreisel D Sankaran D Wells AD Turka LA Interleukin-2-mediated survival and proliferative signals are uncoupled in T lymphocytes that fail to divide after activation Am J Transplant 2002 2 120 8 12099513 

52. 52 Alva A Daniels GA Wong MK Kaufman HL Morse MA McDermott DF Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma Cancer Immunol Immunother 2016 65 1533 44 27714434 

    상세보기

53. 53 Wing K Sakaguchi S Regulatory T cells exert checks and balances on self tolerance and autoimmunity Nat Immunol 2010 11 7 13 20016504 

    상세보기

54. 54 Matsuoka K Koreth J Kim HT Bascug G McDonough S Kawano Y Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease Sci Transl Med 2013 5 179ra43 

    상세보기

55. 55 He J Zhang X Wei Y Sun X Chen Y Deng J Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus Nat Med 2016 22 991 3 27500725 

    상세보기

56. 56 Jyonouchi S Gwafila B Gwalani LA Ahmad M Moertel C Holbert C Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome Clin Immunol 2017 179 47 53 28232030 

    상세보기

57. 57 Koreth J Matsuoka K Kim HT McDonough SM Bindra B Alyea EP 3rd Interleukin-2 and regulatory T cells in graft-versus-host disease N Engl J Med 2011 365 2055 66 22129252 

    상세보기

58. 58 Landy J Ronde E English N Clark SK Hart AL Knight SC Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer World J Gastroenterol 2016 22 3117 26 27003989 

    상세보기

59. 59 Hwang DY Kim S Hong HS Substance-P Ameliorates Dextran Sodium Sulfate-Induced Intestinal Damage by Preserving Tissue Barrier Function Tissue Eng Regen Med 2018 15 63 73 30603535 

60. 60 Dignass AU Podolsky DK Interleukin 2 modulates intestinal epithelial cell function in vitro Exp Cell Res 1996 225 422 9 8660931 

    상세보기

61. 61 Mishra J Waters CM Kumar N Molecular mechanism of interleukin-2-induced mucosal homeostasis Am J Physiol Cell Physiol 2012 302 C735 47 22116305 

    상세보기

62. 62 O'Loughlin EV Pang GP Noltorp R Koina C Batey R Clancy R Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes Gut 2001 49 636 43 11600465 

    상세보기

63. 63 Baeyens A Perol L Fourcade G Cagnard N Carpentier W Woytschak J Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes Diabetes 2013 62 3120 31 23670972 

    상세보기

64. 64 Huber JD Egleton RD Davis TP Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier Trends Neurosci 2001 24 719 25 11718877 

    상세보기

65. 65 Mennigen R Nolte K Rijcken E Utech M Loeffler B Senninger N Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis Am J Physiol Gastrointest Liver Physiol 2009 296 G1140 9 19221015 

66. 66 Alipour M Zaidi D Valcheva R Jovel J Martinez I Sergi C Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis J Crohns Colitis 2016 10 462 71 26660940 

67. 67 Van der Sluis M De Koning BA De Bruijn AC Velcich A Meijerink JP Van Goudoever JB Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection Gastroenterology 2006 131 117 29 16831596 

68. 68 Vivanco I Sawyers CL The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2002 2 489 501 12094235 

    상세보기

69. 69 Peng XD Wu XH Chen LJ Wang ZL Hu XH Song LF Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice J Pharmacol Exp Ther 2010 332 46 56 19828878 

    상세보기

70. 70 Gao W Wang C Yu L Sheng T Wu Z Wang X Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway Biomed Res Int 2019 2019 6769789 31139644 

    상세보기

71. 71 Gao W Zhang L Wang X Yu L Wang C Gong Y The combination of indirubin and isatin attenuates dextran sodium sulfate induced ulcerative colitis in mice Biochem Cell Biol 2018 96 636 45 29671340 

    상세보기

72. 72 Li N Sun W Zhou X Gong H Chen Y Chen D Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-kappaB Signaling Pathways Biomed Res Int 2019 2019 1415809 31781591 

73. 73 Sun Y Zhao Y Wang X Zhao L Li W Ding Y Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-kappaB activation through PI3K/Akt pathway Oncotarget 2016 7 34300 15 27102438 

74. 74 Hu W Jin L Jiang CC Long GV Scolyer RA Wu Q AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma Cell Death Dis 2013 4 e914 24201813 

    상세보기

75. 75 Kumar C Rasool RU Iqra Z Nalli Y Dutt P Satti NK Alkyne-azide cycloaddition analogues of dehydrozingerone as potential anti-prostate cancer inhibitors via the PI3K/Akt/NF-kB pathway Medchemcomm 2017 8 2115 24 30108729 

    상세보기

76. 76 Rahman KM Li Y Sarkar FH Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells Nutr Cancer 2004 48 84 94 15203382 

77. 77 Schwanke RC Marcon R Meotti FC Bento AF Dutra RC Pizzollatti MG Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3K/Akt signaling pathway Mol Nutr Food Res 2013 57 1938 49 23861337 

    상세보기

78. 78 Setia S Nehru B Sanyal SN Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer Biomed Pharmacother 2014 68 1023 9 25443414 

    상세보기

79. 79 Taylor BS de Vera ME Ganster RW Wang Q Shapiro RA Morris SM Jr Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene J Biol Chem 1998 273 15148 56 9614127 

80. 80 Gilbert S Zhang R Denson L Moriggl R Steinbrecher K Shroyer N Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation EMBO Mol Med 2012 4 109 24 22228679 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.